Research and Markets (http://www.researchandmarkets.com/research/t9fc24/chimeric_antigen) has announced the addition of the "Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016" report to their offering.
The report, Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016 emphasizes on the currently active CAR-T cell products in research and development.
The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens.
The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.
Report Highlights:
- CAR-T cell Therapy Pipeline scenario
- Collaborations & partnering deals
- Current Prominent Research Areas and Key Players
- Pipeline product profiles CAR-T Technologies and Targeted Antigens
- Licensing opportunities
- Market Drivers and Barriers
Key Topics Covered:
1 Report Introduction
2 Executive Summary Snapshot
3 Executive Summary
4 Introduction
5 CAR-T Cell Therapy-Analysis
6 Pipeline Profiles
7 Upcoming Technologies Better than CARs
8 Market Drivers
9 Market Barriers
10 SWOT Analysis
11 Report Methodology
12 Consulting Services
For more information visit http://www.researchandmarkets.com/research/t9fc24/chimeric_antigen
View source version on businesswire.com: http://www.businesswire.com/news/home/20160119006073/en/